Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 15,366 | 16,379 | 14,911 | 7,729 | 3,599 |
| Operating Income | -15,366 | -16,379 | -14,911 | -7,729 | -3,599 |
| Other Income | 344 | 955 | 588 | 18 | 15 |
| Pre-tax Income | -15,022 | -15,424 | -14,323 | -7,711 | -3,584 |
| Net Income Continuous | -15,022 | -15,424 | -14,323 | -7,711 | -3,584 |
| Net Income | $-15,022 | $-15,424 | $-14,323 | $-7,711 | $-3,584 |
| EPS Basic Total Ops | -45.10 | -51.26 | -48.46 | -52.94 | -51.54 |
| EPS Basic Continuous Ops | -44.98 | -51.43 | -48.56 | -52.80 | -51.63 |
| EPS Diluted Total Ops | -45.10 | -51.26 | -48.46 | -52.94 | -51.54 |
| EPS Diluted Continuous Ops | -44.98 | -51.43 | -48.56 | -52.80 | -51.63 |
| EPS Diluted Before Non-Recurring Items | -45.10 | -51.26 | -48.46 | -52.94 | -457.14 |
| EBITDA(a) | $-15,365 | $-16,377 | $-14,909 | $-7,728 | $-3,598 |